A widely available commercial weight-management program led to greater reductions in weight than an unstructured, do-it-yourself (DIY) approach, according to new data published recently in JAMA ...

Early weight loss ≥ 2% or ≥ 3% by 4 weeks in structured weight-loss programs is significantly associated with achieving ≥ 5% or ≥ 10% total weight loss, respectively, by 16 weeks in adults with class ...

Johns Hopkins scientists who indirectly investigated the blood sugar effects of 10 (out of 32 selected) commercial weight loss programs say a few show promise of benefit for diabetic patients, but far ...

To qualify for the Medicare Bridge program, you must have Medicare Part D, meet clinical eligibility, and have a prescription for an eligible GLP-1 medication. This medication must be used alongside ...

Kara Burnstine, M.S., R.D.N., L.D.N., C.D.C.E.S. Nutrition / Weight Loss / Diabetes / Cardiovascular Health / Gut Health Kara Burnstine has over 20 years of ...

MALAGA, Spain—Patients with obesity treated with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy; Novo Nordisk) can achieve weight loss in the real world similar to what has ...

Because Valerie Prim grew up in a large Italian family, food has always been an important part of her life. "Everything about food was big," Prim said. "You never thought about what you ate." But a ...

As weight loss medications containing active ingredients like semaglutide continue to define a new chapter in metabolic health care, research into new, similar drugs is on the rise. Here’s everything ...